C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/115 (2010.01) C12N 15/113 (2010.01) A61K 31/7105 (2006.01) A61P 35/00 (2006.01) C07H 21/00 (2006.01) C12N 15/11 (2006.01) C12N 9/12 (2006.01)
Patent
CA 2536015
Compounds comprising an oligonucleotide moiety covalently linked to a lipid moiety are disclosed. The oligonucleotide moiety comprises a sequence that is complementary to the RNA component of human telomerase. The compounds inhibit telomerase activity in cells with a high potency and have superior cellular uptake characteristics.
L'invention concerne des composés comprenant une fraction oligonucléotidique liée de façon covalente à une fraction lipidique. Cette fraction oligonucléotidique comprend une séquence complémentaire au composé d'ARN de la télomérase humaine. Ces composés inhibent l'activité de la télomérase dans les cellules de façon très efficacité et possèdent des caractéristiques d'absorption cellulaire supérieures.
Gryaznov Sergei
Pongracz Krisztina
Geron Corporation
Gowling Lafleur Henderson Llp
LandOfFree
Modified oligonucleotides for telomerase inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified oligonucleotides for telomerase inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified oligonucleotides for telomerase inhibition will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1721441